Thompson Street Capital Partners (TSCP) has announced it has completed a growth investment in Sabai Global.

Sabai, based in Chesterfield, Mo., is a provider of regulatory review and biosafety consulting services. Founded in 2018, the company provides services to pharmaceutical sponsors, clinical research organizations, academic health systems and clinical research site networks.

TSCP, based in St. Louis, Mo., targets investments in middle market companies. Founded in 2000, the firm typically invests in healthcare and a few other sectors. Within healthcare, areas of interest include pharmaceutical logistics, connected health, and regulatory and compliance.

Terms of the investment were not disclosed.